PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy
Go back to PTC Therapeutics Announces FDA Approval of AADC Deficiency Gene Therapy| PTC THERAPEUTICS (NASDAQ: PTCT) | Delayed: 73.67 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $73.67 | 52 Week High | $35.40 | |||
| Open | $73.67 | 52 Week Low | $4.03 | |||
| Day High | $73.67 | P/E | 7.84 | |||
| Day Low | $73.67 | EPS | $9.40 | |||
| Volume | 26 | |||||
